Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway.

Mamoru Watanabe, Motomi Yamazaki, Ryuichi Okamoto, Shinya Ohoka, Akihiro Araki, Tetsuya Nakamura, Takanori Kanai

研究成果: Review article

14 引用 (Scopus)

抜粋

Inflammatory bowel disease is thought to result from inappropriate activation of mucosal immune responses. Intestinal epithelial cells produce interleukin (IL)-7 that serves as a regulatory factor for IL-7 receptor (IL-7R)(+) mucosal lymphocytes. The pivotal role of mucosal IL-7/IL-7R dependent signals in the activation of mucosal immune responses that lead to the development of chronic intestinal inflammation are demonstrated. Therapeutic approaches targeting IL-7/IL-7R signal pathway may be feasible in the treatment of inflammatory bowel disease.

元の言語English
ページ(範囲)119-123
ページ数5
ジャーナルCurrent drug targets. Inflammation and allergy
2
発行部数2
DOI
出版物ステータスPublished - 2003 6
外部発表Yes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

フィンガープリント Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway.' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用